In addition to promoting stemness and drug resistance, some studies also indicated that wild‐type p53 preferentially induces senescence rather than apoptosis in chemotherapy‐treated cancer cells, leading to persistent SASP release that drives disease relapse and reduced survival.56 This evidence concerns the gene TP53 and cancer.